Sign in
4

Changes in Ownership

Gossamer Bio, Inc. Filed Acc 0001728117-23-000145

Options or other derivatives

  • President & CEO acquired 437,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hasnain Faheem President & CEO 2023-11-20 Grant or award · Stock Option (Right to Buy) +437,500 437,500 D
Loading xslF345X05/wk-form4_1700698023.xml…